SIREN : 793891805
APSYS-E is a French company founded 12 years ago, specialized in the sector Travaux d'installation électrique dans tous locaux. Based in NIMES (30900), this company of category PME shows in 2025 a revenue of 3.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 854 959 € | 4 985 505 € | 4 449 830 € | 5 875 385 € | 4 353 662 € | 6 087 490 € | 6 302 747 € | 5 919 773 € | 9 322 223 € |
| Net income | 11 757 € | -161 569 € | 79 321 € | 158 866 € | 81 416 € | 23 812 € | 3 005 € | 104 594 € | 112 753 € |
| EBITDA | 57 064 € | -75 351 € | 116 416 € | 229 049 € | 97 493 € | 87 438 € | 218 € | 96 480 € | 265 115 € |
| Net margin | 0.3% | -3.2% | 1.8% | 2.7% | 1.9% | 0.4% | 0.0% | 1.8% | 1.2% |
In 2025, APSYS-E achieves revenue of 3.9 M€. Revenue is declining over the period 2016-2025 (CAGR: -9.3%). Significant drop of -23% vs 2024. After deducting consumption (1.3 M€), gross margin stands at 2.6 M€, i.e. a rate of 67%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 57 k€, representing 1.5% of revenue. Positive scissor effect: EBITDA margin improves by +3.0 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 12 k€, i.e. 0.3% of revenue. This profit can be retained or distributed to shareholders.
3 854 959 €
2 601 676 €
57 064 €
34 976 €
11 757 €
1.5%
The debt ratio (= Financial debt / Equity x 100) stands at 57%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 19%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.7 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 0.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
56.704%
19.482%
0.762%
3.677
28.5%
In 2025, the debt ratio of APSYS-E (56.70) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of APSYS-E (19.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
In 2025, the repayment capacity of APSYS-E (3.68) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 193.29. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 19.4x. Operating income very largely covers interest expenses: high safety margin.
193.291
19.447
In 2025, the liquidity ratio of APSYS-E (193.29) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2025, the interest coverage of APSYS-E (19.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 96 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 45 days. The gap of 51 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 14 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 66 days of revenue, i.e. 711 k€ to permanently finance. Notable WCR improvement over the period (-49%), freeing up cash.
711 471 €
96 j
45 j
14 j
66 j
Based on 283 transactions of similar company sales (all years), the value of APSYS-E is estimated at 240 769 € (range 137 550€ - 520 775€). With an EBITDA of 57 064€, the sector multiple of 1.0x is applied. The price/revenue ratio is 0.18x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 283 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare APSYS-E with other companies in the same sector:
Voir toutes les statistiques du secteur Travaux d'installation électrique dans tous locaux
The revenue of APSYS-E in 2025 is 3.9 M€.
Yes, APSYS-E generated a net profit of 12 k€ in 2025.
The headquarters of APSYS-E is located in NIMES (30900), in the department Gard.
The tax return of APSYS-E is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
APSYS-E operates in the sector Travaux d'installation électrique dans tous locaux (NAF code 43.21A). See the 'Sector positioning' section above to compare the company with its competitors.